2017
DOI: 10.2174/1568026617666170130122921
|View full text |Cite
|
Sign up to set email alerts
|

Challenges with Mosquito-borne Viral Diseases: Outbreak of the Monsters

Abstract: The vaccines against Zika, dengue and chikungunya viruses are at different stages of development. The challenges associated with the epidemic wave of Zika, dengue and chikungunya viruses have been explained and the current status of drug/ vaccine development against these viruses has been reviewed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 0 publications
0
9
0
Order By: Relevance
“…1(a)). The overall curve fit of the EC 50 for metofluthrin decreased from 0.29 (0.13-0.66) to 0.26 (0.12-0.55) μg cm -2 against the OR strain and from 17 (10-30) to 12 (8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18) against the PR strain ( Fig. 1(a)).…”
Section: Impact Of the Pabt On Calculated Response Potenciesmentioning
confidence: 99%
See 1 more Smart Citation
“…1(a)). The overall curve fit of the EC 50 for metofluthrin decreased from 0.29 (0.13-0.66) to 0.26 (0.12-0.55) μg cm -2 against the OR strain and from 17 (10-30) to 12 (8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18) against the PR strain ( Fig. 1(a)).…”
Section: Impact Of the Pabt On Calculated Response Potenciesmentioning
confidence: 99%
“…Infection rates stemming from these diseases affect millions of people worldwide and are likely to increase . Even though vaccines have been developed and are available, the efficacy against dengue is limited to about 59% and no vaccine for Zika virus has been approved for clinical use . Due to the limited efficacy of vaccines for Zika, dengue, and chikungunya viruses, and problems with the feasibility of practical use and public acceptance of genetically modified mosquitoes, vector control by chemicals is still the major strategy for controlling disease transmission.…”
Section: Introductionmentioning
confidence: 99%
“…Besides humans, the main vectors of the virus in nature are mosquitoes from the genus Aedes ( 73 ). These vectors contribute not only to Dengue outbreak but also to the spread of other mosquito-borne diseases, like Zika and chikungunya ( 85 , 86 ). Vaccines for these diseases are at different stages of development, no specific treatment is available, and diagnostic methods are limited.…”
Section: Versatile Vhh Approaches For Ntdsmentioning
confidence: 99%
“…30 Changes in the mosquito populations, host populations, and viral virulence (including neuroinvasion) and geographical spread into na€ ıve populations could create complex interactions that could cause epidemics of viral infection and large numbers of survivors with physical and mental impairment, including the zombie phenotype. 31,32…”
Section: Virusesmentioning
confidence: 99%